AMAndrea Maturana-Ramírez

Andrea Maturana-Ramírez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andrea Maturana-Ramírez has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Activation of Wnt/β-catenin signaling in histologically non-dysplastic non-homogeneous oral leukoplakia

    by Daniel Peña-Oyarzún, Andrea Maturana-Ramírez, Montserrat Reyes

    Oral potentially malignant disorders (OPMD) are lesions that precede oral cancer in approximately 15–40% of cases. Leukoplakia is the most frequent t

  • Open Access

    Hypovitaminosis D in patients with oral leukoplakia: insights from a cross-sectional study

    by Andrea Maturana-Ramirez, Juan Aitken-Saavedra, Dante Mora-Ferraro, Gabriel Rojas-ZúñiGa, Iris Espinoza-Santander, Gonzalo Rojas-Alcayaga, Ana Ortega-Pinto, Montserrat Reyes, Diego Lazo, Egardo Caamanão

    Introduction: Oral leukoplakia is one of the most frequent oral potentially malignant disorders. The present study aims to compare serum vitamin D levels between patients with and without oral leukoplakia, by smoking habit.Methods: This cross-sectional study involved a group of 45 cases with oral leukoplakia and a control group with 45 individuals. In both groups a pathology report was done, and for leukoplakia a binary classification of low- and high-grade epithelial dysplasia was employed. Serum 25(OH)D3 vitamin D levels, and data on smoking status, age, gender, comorbidities, and clinical and pathological characteristics were collected for both groups.Results: vitamin D levels were lower in the oral leukoplakia group with a median of 19.1 ng/ml, while the control group had a median of 24.8 ng/ml. When subdividing each group by smoking habit, the smoking case group had a median of 19.4 ng/ml (IQR: 15.7-21.5 ng/ml), the non-smoking case group had 18.8 ng/ml (IQR: 13.6-29.2 ng/ml), the smoking control group had 21.8 ng/ml (IQR: 17.5-27.3 ng/ml), and the non-smoking control group had 25.4 ng/ml (IQR: 20.4-32.9 ng/ml) (p<0.05). When comparing serum vitamin D levels, statistically significant differences were found between the smoking case group versus the non-smoking control group and between the non-smoking case group versus the non-smoking control group (p<0.05). Serum vitamin D levels by histopathological diagnosis showed no differences between leukoplakia groups.Discussion: This study shows that serum vitamin D levels were lower in patients with OL compared to those without OL, which was more evident in the smoking group. Patients with OL were previously observed to have hypovitaminosis D, without assessing smoking habits. This finding suggests a possible role of vitamin D deficiency in the development of OL, which could be more marked in smokers. This opens the possibility of future research on vitamin D as a chemopreventive agent in the malignant transformation of OL, and to evaluate the relationship between smoking and hypovitaminosis D.


  • Open Access

    Hypovitaminosis D in patients with oral squamous cell carcinoma: Is a risk factor of developing this neoplasia?

    by A. Maturana-Ramiìrez, J. Aitken-Saavedra, G. Rojas-Zúñiga, G. Rojas-Alcayaga, I. Espinoza-Santander, A. Rebolledo, R. Fuentes, M. Reyes-Rojas, C. Araya, D. Lazo, et al.

    Background: Hypovitaminosis D raised a significant public health concern due to its potential association withvar- ious diseases, including Oral Squamous Cell Carcinoma (OSCC). The objective of this study was to compare serum 25(OH)D3 levels between individuals with and without OSCC, and by subgroups based on their smoking habits. Material and Methods: A case-control study was conducted utilizing progressive multicenter recruitment, involving 46 patients with Oral Squamous Cell Carcinoma (OSCC) and 65 controls. Serum levels of 25(OH)D3 were evaluated via electrochemiluminescence. Patients were categorized according to their vitamin D levels into sufficiency, mild deficiency, moderate deficiency, and severe deficiency. Comparative analyses of serum 25(OH)D3 levels were performed between OSCC patients and controls, as well as among subgroups based on their smoking habits. Group comparisons were made with the Mann-Whitney test, and subgroup analyses used the Kruskal-Wallis test. Significance was set atp < 0.05 Results: 91% of participants, including both OSCC patients and controls, exhibited some degree of 25(OH)D3 deficiency. Among them, 71.7% of OSCC patients and 50.7% of controls had serum levels characterized by moderate to severe deficiencies. Patients with OSCC showed lower levels of 25(OH)D3, with medians of 20.2 ng/ml (IQR 9.48), compared to controls, with medians of 24.8 ng/ml (IQR 9.13) (p=0.002). Furthermore, when comparing the medians among the four study groups (smoking and non-smoking controls and smoking and non-smoking patients with OSCC), a significant difference was observed between non-smoking control patients with 25.04 ng/ml (IQR = 9.71) and smoking OSCC patients with 19.65 ng/ml (IQR = 12.14) (p < 0.05). Conclusions: Individuals with oral squamous cell carcinoma (OSCC) exhibited lower serum levels of vitamin D (25(OH)D3) compared to controls, suggesting a potential link between vitamin deficiency and the development of this type of cancer. Vitamin D supplementation could serve as a preventive and therapeutic strategy.


  • Open Access

    Idiopathic gingival papillokeratosis with crypt formation: an exclusive entity in the young population?

    by Macarena Salinas-Munoz, Juan Aitken-Saavedra, Andrea Maturana-Ramirez

    Idiopathic gingival papillokeratosis with crypt formation (IGPC) is a new and a very rare benign entity, clinically characterized by white-yellowish plaques with papillary architecture located in the upper labial gingiva of adolescent patients. The condition generally exhibits a bilateral symmetrical distribution and is asymptomatic. We report two new cases, one with a classic presentation and the other in an older individual. Through these case reports, we describe and highlight the key clinical and histopathological features associated with IGPC for greater understanding and knowledge by general dentists, oral pathologists, and dermatologists.


  • Open Access

    Calcitriol Treatment Decreases Cell Migration, Viability and β-Catenin Signaling in Oral Dysplasia

    by Daniel Peña-Oyarzún, Constanza Guzmán, Catalina Kretschmar, Vicente A. Torres, Andrea Maturana-Ramirez, Juan Aitken, Montserrat Reyes

    Nearly 90% of oral cancers are characterized as oral squamous cell carcinoma (OSCC), representing the sixth most common type of cancer. OSCC usually evolves from oral potentially malignant disorders that, in some cases, are histologically consistent with a oral dysplasia. The levels of 1α,25 dihydroxyvitamin D3 (1,25-(OH)2D3; calcitriol), the active form of vitamin D3, have been shown to be decreased in patients with oral dysplasia and OSCC. Moreover, treatment with 1,25-(OH)2D3 has been proven beneficial in OSCC by inhibiting the Wnt/β-catenin pathway, a signaling route that promotes cell migration, proliferation, and viability. However, whether this inhibition mechanism occurs in oral dysplasia is unknown. To approach this question, we used dysplastic oral keratinocyte cultures and oral explants (ex vivo model of oral dysplasia) treated with 1,25-(OH)2D3 for 48 h. Following treatment with 1,25-(OH)2D3, both in vitro and ex vivo models of oral dysplasia showed decreased levels of nuclear β-catenin by immunofluorescence (IF) and immunohistochemistry (IHC). Consistently, reduced protein and mRNA levels of the Wnt/β-catenin target gene survivin were observed after treatment with 1,25-(OH)2D3. Moreover, 1,25-(OH)2D3 promoted membranous localization of E-cadherin and nuclear localization of vitamin D receptor (VDR). Functionally, DOK cells treated with 1,25-(OH)2D3 displayed diminished cell migration and viability in vitro.


  • Open Access

    Supplementary Figure S2 from Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis

    by Daniel Peña-Oyarzún, Tania Flores, Vicente A. Torres, Andrew F.G. Quest, Lorena Lobos-González, Catalina Kretschmar, Pamela Contreras, Andrea Maturana-Ramírez, Alfredo Criollo, Montserrat Reyes

    Specificity of C59 over endogenous Wnt3a signaling in DOK-TC cells

  • Open Access

    Supplementary Figure S5 from Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis

    by Daniel Peña-Oyarzún, Tania Flores, Vicente A. Torres, Andrew F.G. Quest, Lorena Lobos-González, Catalina Kretschmar, Pamela Contreras, Andrea Maturana-Ramírez, Alfredo Criollo, Montserrat Reyes

    Clinical presentation of human oral lesions used as oral carcinogenesis ex vivo modeL

  • Open Access

    Supplementary Figure S4 from Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis

    by Daniel Peña-Oyarzún, Tania Flores, Vicente A. Torres, Andrew F.G. Quest, Lorena Lobos-González, Catalina Kretschmar, Pamela Contreras, Andrea Maturana-Ramírez, Alfredo Criollo, Montserrat Reyes

    Effect of C59 on cell invasion in CAL-27 cells

  • Open Access

    Supplementary Figure S1 from Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis

    by Daniel Peña-Oyarzún, Tania Flores, Vicente A. Torres, Andrew F.G. Quest, Lorena Lobos-González, Catalina Kretschmar, Pamela Contreras, Andrea Maturana-Ramírez, Alfredo Criollo, Montserrat Reyes

    Characterization of the in vitro human oral carcinogenesis model

  • Open Access

    Supplementary Figure S5 from Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis

    by Daniel Peña-Oyarzún, Tania Flores, Vicente A. Torres, Andrew F.G. Quest, Lorena Lobos-González, Catalina Kretschmar, Pamela Contreras, Andrea Maturana-Ramírez, Alfredo Criollo, Montserrat Reyes

    Clinical presentation of human oral lesions used as oral carcinogenesis ex vivo modeL